BPC-157 (10mg)
BPC-157 (10mg)
Couldn't load pickup availability
BPC-157 (10mg)
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide consisting of 15 amino acids, originally identified as a fragment of a naturally occurring protein in human gastric juice. With a molecular weight of 1419.5 g/mol and verified purity of ≥99% (HPLC), BPC-157 is supplied in lyophilized powder form for laboratory research applications. Its stability and consistency make it a valuable material for scientific studies exploring peptide activity in controlled settings.
Disclaimer: This product is intended strictly for research use only and is not for human consumption, therapeutic, or diagnostic purposes.
- Fast Shipping
99% Purity
- Made in USA
What is BPC-157?
BPC-157 is a synthetic 15-amino acid peptide sequence originally identified in human gastric juice. This research compound has been extensively studied in laboratory settings for its interactions with tissue repair pathways, angiogenesis processes, and cellular protective mechanisms. The peptide represents a partial sequence of the naturally occurring body protection compound and has become a subject of significant scientific interest. Research investigations have examined its molecular interactions with various biological systems, including wound healing cascades, vascular development processes, and inflammatory response pathways.
Chemical Structure of BPC‑157
BPC-157 is a pentadecapeptide with the amino acid sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. The compound has a molecular formula of C₆₂H₉₈N₁₆O₂₂ and molecular weight of 1419.556 g/mol (PubChem CID: 108101). This synthetic peptide demonstrates notable stability under standard laboratory conditions and maintains structural integrity across various pH environments, making it suitable for diverse experimental protocols. The compound is also referenced in scientific literature as Body Protection Compound-157, reflecting its original identification and isolation from human gastric secretions.
Research and Clinical Studies on BPC-157
1. Cellular Repair & Tissue Studies: Laboratory investigations have examined BPC-157's interactions with fibroblast proliferation, collagen synthesis, and angiogenic signaling in tissue culture models. Research has documented the peptide's influence on extracellular matrix formation, cellular migration, and key proteins including focal adhesion kinase (FAK) and paxillin phosphorylation pathways.
2. Gastrointestinal Research Models: Scientific studies have explored BPC-157's molecular mechanisms in gastric protection models, examining interactions with mucosal barrier systems and epithelial cell signaling. Research has documented the peptide's stability across pH environments and its role in villus-crypt architecture studies under experimental conditions.
3. Vascular Biology & Angiogenesis Research: Experimental protocols have investigated BPC-157's influence on VEGF expression, endothelial cell migration, and nitric oxide signaling. Studies have examined interactions with human umbilical vein endothelial cells (HUVECs) and documented influence on extracellular signal-regulated kinases (ERK1/2) in angiogenic pathway studies.
4. Neurological & Organ Protection Research: Preclinical studies have examined BPC-157's interactions with neural protection pathways, stress response mechanisms, and neurotransmitter system modulation in controlled experimental conditions. Laboratory investigations have explored its influence on dopaminergic signaling pathways and its interactions with various neurotransmitter systems. Research protocols have documented the peptide's role in traumatic brain injury models and its interactions with brain edema reduction mechanisms in experimental settings.
5. Inflammation & Oxidative Stress Research: Laboratory analyses have comprehensively documented BPC-157's interactions with inflammatory mediator pathways, cytokine expression patterns, and oxidative stress marker modulation in cellular and tissue models. Studies have investigated its influence on prostaglandin systems, nitric oxide pathway regulation, and antioxidant mechanism interactions. Research has examined the peptide's role in reactive oxygen species neutralization and its interactions with various stress response signaling cascades.
6. Safety & Toxicological Research: Extensive toxicological studies have evaluated BPC-157's safety profile across multiple experimental protocols, with comprehensive documentation of low cytotoxicity profiles in laboratory conditions. Research has examined the peptide's biocompatibility across various administration routes, its stability under physiological conditions, and long-term exposure studies in experimental models. Laboratory investigations have documented minimal adverse reactions and have established safety parameters for research applications across diverse experimental protocols.